Treatment of AL amyloidosis with high dose therapy and autologous stem cell transplantation

被引：1

作者：

Dimopoulos, Meletios A. ^{[1
]}

机构：

[1] Univ Athens, Sch Med, Dept Clin Therapeut, GR-11527 Athens, Greece

来源：

LEUKEMIA & LYMPHOMA | 2006年 / 47卷 / 06期

关键词：

D O I：

10.1080/10428190600647509

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

收藏

页码：963 / 964

页数：2

相关论文

共 11 条

[1]

Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: One-year follow-up in five patients [J].

Comenzo, RL ;

Vosburgh, E ;

Simms, RW ;

Bergethon, P ;

Sarnacki, D ;

Finn, K ;

Dubrey, S ;

Faller, DV ;

Wright, DG ;

Falk, RH ;

Skinner, M .

BLOOD, 1996, 88 (07) :2801-2806

[2]

Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study [J].

Dispenzieri, A ;

Kyle, RA ;

Lacy, MQ ;

Therneau, TM ;

Larson, DR ;

Plevak, MF ;

Rajkumar, SV ;

Fonseca, R ;

Greipp, PR ;

Witzig, TE ;

Lust, JA ;

Zeldenrust, SR ;

Snow, DS ;

Hayman, SR ;

Litzow, MR ;

Gastineau, DA ;

Tefferi, A ;

Inwards, DJ ;

Micallef, IN ;

Ansell, SM ;

Porrata, LF ;

Elliott, MA ;

Gertz, MA .

BLOOD, 2004, 103 (10) :3960-3963

[3]

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis [J].

Gertz, MA ;

Comenzo, R ;

Falk, RH ;

Fermand, JP ;

Hazenberg, BP ;

Hawkins, PN ;

Merlini, G ;

Moreau, P ;

Ronco, P ;

Sanchorawala, V ;

Sezer, O ;

Solomon, A ;

Grateau, G .

AMERICAN JOURNAL OF HEMATOLOGY, 2005, 79 (04) :319-328

[4]

PRIMARY SYSTEMIC AMYLOIDOSIS - A RARE COMPLICATION OF IMMUNOGLOBULIN-M MONOCLONAL GAMMOPATHIES AND WALDENSTROMS MACROGLOBULINEMIA [J].

GERTZ, MA ;

KYLE, RA ;

NOEL, P .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (05) :914-920

[5]

Amyloidosis associated with chronic lymphocytic leukemia [J].

Ikee, R ;

Kobayashi, S ;

Hemmi, N ;

Suzuki, S ;

Miura, S .

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2005, 12 (02) :131-134

[6]

Jaccard A, 2005, BLOOD, V106, p127A

[7]

Excessive fluid accumulation during stem cell mobilization: a novel prognostic factor of first-year survival after stem cell transplantation in AL amyloidosis patients [J].

Leung, N ;

Leung, TR ;

Cha, SS ;

Dispenzieri, A ;

Lacy, MQ ;

Gertz, MA .

BLOOD, 2005, 106 (10) :3353-3357

[8]

High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial [J].

Sanchorawala, V ;

Wright, DG ;

Seldin, DC ;

Falk, RH ;

Finn, KT ;

Dember, LM ;

Berk, JL ;

Quillen, K ;

Anderson, JJ ;

Comenzo, RL ;

Skinner, M .

BONE MARROW TRANSPLANTATION, 2004, 33 (04) :381-388

[9]

High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: An 8-year study [J].

Skinner, M ;

Sanchorawala, V ;

Seldin, DC ;

Dember, LM ;

Falk, RH ;

Berk, JL ;

Anderson, JJ ;

O'Hara, C ;

Finn, KT ;

Libbey, CA ;

Wiesman, J ;

Quillen, K ;

Swan, N ;

Wright, DG .

ANNALS OF INTERNAL MEDICINE, 2004, 140 (02) :85-93

[10]

Autologous stem cell transplantation and IgM amyloidosis [J].

Valente, Maria ;

Roy, Vivek ;

Lacy, Martha Q. ;

Dispenzieri, Angela ;

Gertz, Morie A. .

LEUKEMIA & LYMPHOMA, 2006, 47 (06) :1006-1012